RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ALXO
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

ALX Oncology Holdings Inc. stock price ended at $5.72 on Tuesday, after losing 4.51%.
(Updated on Jul 02, 2024)

Sell candidate since May 23, 2024 Loss -61.06% PDF

The ALX Oncology Holdings Inc. stock price fell by -4.51% on the last day (Tuesday, 2nd Jul 2024) from $5.99 to $5.72. During the last trading day the stock fluctuated 5.61% from a day low at $5.70 to a day high of $6.02. The price has fallen in 8 of the last 10 days and is down by -22.49% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -201 thousand shares and in total, 460 thousand shares were bought and sold for approximately $2.63 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -44.53% during the next 3 months and, with a 90% probability hold a price between $0.750 and $6.53 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ALXO Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The ALX Oncology Holdings Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $6.08 and $9.91. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, May 07, 2024, and so far it has fallen -67.43%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for ALX Oncology Holdings Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.320 between high and low, or 5.61%. For the last week, the stock has had daily average volatility of 10.29%.

ALX Oncology Holdings Inc. is oversold on RSI14 (7). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ALXO) For The Upcoming Trading Day Of Wednesday 3rd

For the upcoming trading day on Wednesday, 3rd we expect ALX Oncology Holdings Inc. to open at $5.81, and during the day (based on 14 day Average True Range), to move between $4.97 and $6.47, which gives a possible trading interval of +/-$0.746 (+/-13.04%) up or down from last closing price. If ALX Oncology Holdings Inc. takes out the full calculated possible swing range there will be an estimated 26.07% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $5.88, some $0.160 (2.80%) from the current price of $5.72, our system finds the risk reward not very attractive.

Is ALX Oncology Holdings Inc. stock A Buy?

ALX Oncology Holdings Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.479 Sell Candidate Unchanged

Predicted Opening Price for ALX Oncology Holdings Inc. of Wednesday, July 3, 2024

Fair opening price July 3, 2024 Current price
$5.81 ( 1.63%) $5.72

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ALXO

Fibonacci Support & Resistance Levels

Level Price
R3 6.13 7.23%
R2 6.01 5.09%
R1 5.94 3.77%
Price 5.72
S1 5.69 -0.505%
S2 5.62 -1.83%
S3 5.49 -3.96%

Accumulated Volume Support & Resistance Levels

Level Price
R3 6.57 14.86%
R2 6.03 5.42%
R1 5.88 2.80%
Price 5.72
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for ALX Oncology Holdings Inc. Stock and on which exchange is it traded?
The symbol for ALX Oncology Holdings Inc. is ALXO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ALX Oncology Holdings Inc. Stock?
ALX Oncology Holdings Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy ALX Oncology Holdings Inc. Stock?
ALX Oncology Holdings Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ALX Oncology Holdings Inc. Stock.

What's the current price of ALX Oncology Holdings Inc. Stock?
As of the end of day on the Jul 02, 2024, the price of an ALX Oncology Holdings Inc. (ALXO) share was $5.72.

What is the 52-week high and low for ALX Oncology Holdings Inc. Stock?
The 52-week high for ALX Oncology Holdings Inc. Stock is $17.81 and the 52-week low is $3.94.

What is the market capitalization of ALX Oncology Holdings Inc. Stock?
As of the Jul 02, 2024, the market capitalization of ALX Oncology Holdings Inc. is 312.08M.

When is the next earnings date for ALX Oncology Holdings Inc.?
The upcoming earnings date for ALX Oncology Holdings Inc. is Aug 08, 2024.
Click to get the best stock tips daily for free!

About ALX Oncology Holdings Inc.

ALX Oncology Holdings. ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hodgkin's lymphoma, as well as a range of solid tumor indications, including head and neck squamous cell c... ALXO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT